Conversely, the high heterogeneity observed in bipolar disorder suggests that orexin-A alterations may be state-dependent (fluctuating between manic and depressive episodes) or modulated by psychotropic medications, rather than serving as a static trait marker. Here, HCRT is linked to bipolar disorder.